上海市长、发改委副主任及相关部委研究推进生物医药产业发展

2019-12-07 佚名 澎湃讯

上海推进科技创新中心建设办公室12月6日召开第十一次全体会议,总结今年科创中心建设情况,研究推进上海生物医药等产业发展。市委副书记、市长应勇,国家发展改革委副主任林念修共同主持会议并讲话。应勇指出,习近平总书记考察上海重要讲话精神,为上海推进科创中心建设提供了根本遵循。明年是科创中心建设形成基本框架之年,要咬定目标,再接再厉,全力推进,更好发挥创新引领和辐射示范作用。生物医药产业是上海优先发展的重

上海推进科技创新中心建设办公室12月6日召开第十一次全体会议,总结今年科创中心建设情况,研究推进上海生物医药等产业发展。市委副书记、市长应勇,国家发展改革委副主任林念修共同主持会议并讲话。应勇指出,习近平总书记考察上海重要讲话精神,为上海推进科创中心建设提供了根本遵循。明年是科创中心建设形成基本框架之年,要咬定目标,再接再厉,全力推进,更好发挥创新引领和辐射示范作用。生物医药产业是上海优先发展的重点领域之一,要夯实优势,瞄准前沿,加快将上海打造成为具有国际影响力的生物医药产业创新高地,为更好地服务国家战略作出更大的贡献。
 
会上,市委常委、副市长吴清通报了今年上海科创中心工作进展和2020年重点工作。国家发展改革委通报了促进集成电路、人工智能、生物医药产业发展工作情况。张江复旦国际创新中心、复旦大学国家集成电路产教融合创新平台、上海交通大学张江科学园、同济大学国家干细胞转化资源库揭牌。科技部党组成员陆明、人社部副部长汤涛、中国科学院副院长相里斌、中国工程院副院长钟志华,上海市副市长宗明,在沪高校领导焦扬、姜斯宪、陈杰,上海张江综合性国家科学中心办公室常务副主任施尔畏出席会议。

应勇指出,市委、市政府对科创中心建设高度重视。今年以来,科创中心建设总体进展良好,策源能力持续增强,高质量创新资源加快集聚,创新链与产业链加快融合,创新创业生态加快优化,市人大正在积极推进立法。明年要将强化科技创新策源功能作为主攻方向,加快形成科创中心基本框架。要突出重点区域,持续聚焦张江,以张江综合性国家科学中心为依托,打造创新策源的战略高地。要突出重点领域,聚焦集成电路、人工智能、生物医药等重点领域,力争在突破关键核心技术、培育世界级新兴产业集群上取得更大进展。要突出重点环节,加强科技体制机制创新,着力打造更好的创新创业环境。要发挥好“三大任务、一大平台”的带动作用,抓紧谋划今后五年上海科创中心建设工作。生物医药产业是我国战略性新兴产业的主攻方向,希望在国家各部门的大力支持下,推动上海在生物医药前沿领域和核心关键技术、临床医学研究、培育创新型领军企业、优化产业生态环境等方面实现更大突破。

林念修指出,今年是上海科创中心建设的深化推进年,推出了一批硬招实招,产出了一批标志性的成果。明年要形成科创中心基本框架,就要把习近平总书记对科技工作系列重要讲话精神和考察上海重要讲话精神作为根本遵循,一张蓝图绘到底。各部门要高效协同,努力形成一批叫得响的标志性成果,全面完成首期任务,让上海的创新体系全起来、创新能力强起来、经济质量高起来、创新生态活起来。同时,要把更多重大任务、重大项目、重大改革交给上海,让下一阶段科创中心建设更有针对性、更有显示度。当前,全球生物医药产业正处在科技革命和产业变革实现重大突破的历史关口,要全力支持上海打造生物医药产业高地,筑牢原始创新的内核,攻克关键核心技术,落实好重大改革举措,带领我国生物医药产业实现高质量发展。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1690263, encodeId=838c169026318, content=<a href='/topic/show?id=805b244019d' target=_blank style='color:#2F92EE;'>#产业发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24401, encryptionId=805b244019d, topicName=产业发展)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=208e29003854, createdName=12498fa0m20暂无昵称, createdTime=Mon May 11 17:13:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636368, encodeId=9f14163636846, content=<a href='/topic/show?id=56f63e8706d' target=_blank style='color:#2F92EE;'>#发改委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37870, encryptionId=56f63e8706d, topicName=发改委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=569522619490, createdName=ms6519009802973839, createdTime=Sat Apr 18 02:13:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409957, encodeId=50bd140995e45, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Dec 09 03:13:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443976, encodeId=75e314439e62b, content=<a href='/topic/show?id=e7601992ea4' target=_blank style='color:#2F92EE;'>#上海市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19927, encryptionId=e7601992ea4, topicName=上海市)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZjNAt5tmhEibeth6ic6albyTSZPiaJWo65S17HKWhSicCsY9SmjRJgPut2nqfvkiblrkZtv1T8vPSCAQ/132, createdBy=ad4d5130176, createdName=ms3046638856685384, createdTime=Mon Dec 09 03:13:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620492, encodeId=5fbf1620492fa, content=<a href='/topic/show?id=a2f26926177' target=_blank style='color:#2F92EE;'>#生物医药产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69261, encryptionId=a2f26926177, topicName=生物医药产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=062820130374, createdName=bluefate128, createdTime=Mon Dec 09 03:13:00 CST 2019, time=2019-12-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1690263, encodeId=838c169026318, content=<a href='/topic/show?id=805b244019d' target=_blank style='color:#2F92EE;'>#产业发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24401, encryptionId=805b244019d, topicName=产业发展)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=208e29003854, createdName=12498fa0m20暂无昵称, createdTime=Mon May 11 17:13:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636368, encodeId=9f14163636846, content=<a href='/topic/show?id=56f63e8706d' target=_blank style='color:#2F92EE;'>#发改委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37870, encryptionId=56f63e8706d, topicName=发改委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=569522619490, createdName=ms6519009802973839, createdTime=Sat Apr 18 02:13:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409957, encodeId=50bd140995e45, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Dec 09 03:13:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443976, encodeId=75e314439e62b, content=<a href='/topic/show?id=e7601992ea4' target=_blank style='color:#2F92EE;'>#上海市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19927, encryptionId=e7601992ea4, topicName=上海市)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZjNAt5tmhEibeth6ic6albyTSZPiaJWo65S17HKWhSicCsY9SmjRJgPut2nqfvkiblrkZtv1T8vPSCAQ/132, createdBy=ad4d5130176, createdName=ms3046638856685384, createdTime=Mon Dec 09 03:13:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620492, encodeId=5fbf1620492fa, content=<a href='/topic/show?id=a2f26926177' target=_blank style='color:#2F92EE;'>#生物医药产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69261, encryptionId=a2f26926177, topicName=生物医药产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=062820130374, createdName=bluefate128, createdTime=Mon Dec 09 03:13:00 CST 2019, time=2019-12-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1690263, encodeId=838c169026318, content=<a href='/topic/show?id=805b244019d' target=_blank style='color:#2F92EE;'>#产业发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24401, encryptionId=805b244019d, topicName=产业发展)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=208e29003854, createdName=12498fa0m20暂无昵称, createdTime=Mon May 11 17:13:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636368, encodeId=9f14163636846, content=<a href='/topic/show?id=56f63e8706d' target=_blank style='color:#2F92EE;'>#发改委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37870, encryptionId=56f63e8706d, topicName=发改委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=569522619490, createdName=ms6519009802973839, createdTime=Sat Apr 18 02:13:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409957, encodeId=50bd140995e45, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Dec 09 03:13:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443976, encodeId=75e314439e62b, content=<a href='/topic/show?id=e7601992ea4' target=_blank style='color:#2F92EE;'>#上海市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19927, encryptionId=e7601992ea4, topicName=上海市)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZjNAt5tmhEibeth6ic6albyTSZPiaJWo65S17HKWhSicCsY9SmjRJgPut2nqfvkiblrkZtv1T8vPSCAQ/132, createdBy=ad4d5130176, createdName=ms3046638856685384, createdTime=Mon Dec 09 03:13:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620492, encodeId=5fbf1620492fa, content=<a href='/topic/show?id=a2f26926177' target=_blank style='color:#2F92EE;'>#生物医药产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69261, encryptionId=a2f26926177, topicName=生物医药产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=062820130374, createdName=bluefate128, createdTime=Mon Dec 09 03:13:00 CST 2019, time=2019-12-09, status=1, ipAttribution=)]
    2019-12-09 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=1690263, encodeId=838c169026318, content=<a href='/topic/show?id=805b244019d' target=_blank style='color:#2F92EE;'>#产业发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24401, encryptionId=805b244019d, topicName=产业发展)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=208e29003854, createdName=12498fa0m20暂无昵称, createdTime=Mon May 11 17:13:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636368, encodeId=9f14163636846, content=<a href='/topic/show?id=56f63e8706d' target=_blank style='color:#2F92EE;'>#发改委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37870, encryptionId=56f63e8706d, topicName=发改委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=569522619490, createdName=ms6519009802973839, createdTime=Sat Apr 18 02:13:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409957, encodeId=50bd140995e45, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Dec 09 03:13:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443976, encodeId=75e314439e62b, content=<a href='/topic/show?id=e7601992ea4' target=_blank style='color:#2F92EE;'>#上海市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19927, encryptionId=e7601992ea4, topicName=上海市)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZjNAt5tmhEibeth6ic6albyTSZPiaJWo65S17HKWhSicCsY9SmjRJgPut2nqfvkiblrkZtv1T8vPSCAQ/132, createdBy=ad4d5130176, createdName=ms3046638856685384, createdTime=Mon Dec 09 03:13:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620492, encodeId=5fbf1620492fa, content=<a href='/topic/show?id=a2f26926177' target=_blank style='color:#2F92EE;'>#生物医药产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69261, encryptionId=a2f26926177, topicName=生物医药产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=062820130374, createdName=bluefate128, createdTime=Mon Dec 09 03:13:00 CST 2019, time=2019-12-09, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1690263, encodeId=838c169026318, content=<a href='/topic/show?id=805b244019d' target=_blank style='color:#2F92EE;'>#产业发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24401, encryptionId=805b244019d, topicName=产业发展)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=208e29003854, createdName=12498fa0m20暂无昵称, createdTime=Mon May 11 17:13:00 CST 2020, time=2020-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636368, encodeId=9f14163636846, content=<a href='/topic/show?id=56f63e8706d' target=_blank style='color:#2F92EE;'>#发改委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37870, encryptionId=56f63e8706d, topicName=发改委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=569522619490, createdName=ms6519009802973839, createdTime=Sat Apr 18 02:13:00 CST 2020, time=2020-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409957, encodeId=50bd140995e45, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Mon Dec 09 03:13:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443976, encodeId=75e314439e62b, content=<a href='/topic/show?id=e7601992ea4' target=_blank style='color:#2F92EE;'>#上海市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19927, encryptionId=e7601992ea4, topicName=上海市)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZjNAt5tmhEibeth6ic6albyTSZPiaJWo65S17HKWhSicCsY9SmjRJgPut2nqfvkiblrkZtv1T8vPSCAQ/132, createdBy=ad4d5130176, createdName=ms3046638856685384, createdTime=Mon Dec 09 03:13:00 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620492, encodeId=5fbf1620492fa, content=<a href='/topic/show?id=a2f26926177' target=_blank style='color:#2F92EE;'>#生物医药产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69261, encryptionId=a2f26926177, topicName=生物医药产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=062820130374, createdName=bluefate128, createdTime=Mon Dec 09 03:13:00 CST 2019, time=2019-12-09, status=1, ipAttribution=)]

相关资讯

我国生物医药产业发展领先城市政策导向

通过梳理我国生物医药产业发展领先城市出台的相关生物医药产业促进政策,本文主要研究其政策导向和策略,从政策层面总结先进城市促进产业发展的领先经验,对其他地区制定产业政策具有一定借鉴意义。 一、国内重点城市生物医药产业发展促进政策对比研究

热门城市的生物医药产业人才供给盘点

人才是企业发展的核心要素。经过对有选址计划的企业调研统计发现,当一家企业要在一个城市进行新的投资时,一定有两个关键点会考虑到人才,一是企业的经营成本,其中考虑到的是人才获得的成本,二是会从考虑人才的可获得性。首先我们从人才流动与GDP的维度进行分析。

一、城市净流入人口数与GDP增长正相关

一个区域能否获得持续性的高成长,人口的持续净流入也成为其保障基础。因为人口的增加会带动房产、服务业、金融业、生产制造等各行各业的发展。我们以2018年GDP过1万亿的16个城市来看经济增长与人口的关系。

河南省新增15家新型研发机构 领域涉信息技术、生物医药等

记者从河南省科技厅获悉,郑州信大捷安信息技术股份有限公司等15家新型研发机构已于近日备案,河南省的新型研发机构总数达到82家。此次备案的15家新型研发机构通过省部会商、院地合作、联合共建等多种形式组建,聚焦战略性新兴产业、传统优势产业、区域特色产业需求,主要在信息技术、生物医药、节能环保、新材料、农业等领域为企业和区域产业发展提供科技创新支撑。其中,洛阳智能农业装备研究院有限公司由中国一拖、中联重

重磅!艾昆纬西部运营总部落户成都高新区

成都高新区良好的生物医药产业发展环境吸引世界知名企业纷纷入驻,距世界500强吉利德科学西部运营中心入驻仅一周时间,成都高新区又迎来全球最大医疗研究服务公司艾昆纬西部运营总部。7月16日,成都高新区生物产业生态圈发展对话会暨成都高新区生物产业(天府国际生物城)推介活动在上海举行,艾昆纬中国中西部首个投资项目——艾昆纬西部运营总部签约落户成都高新区,将建设国际领先、中国中西部首个全球顶尖CRO企业直接

勃林格殷格翰广撒“英雄帖” 生物医药“创新大赛”正式启动

2019年11月7日,在第二届中国国际进口博览会上,德国药企勃林格殷格翰宣布其创新大赛正式在中国启动, 这是跨国药企在中国主办的首个生物医药类创新竞赛,旨在与中国创新企业或个人展开全方位互动与合作、激励中国本土创新。 “研发创新是我们长期发展的原动力。如今,前所未有的科学创新正在中国频频呈现,这里正迅速成为全世界生物医药研究的创新枢纽。”勃林格殷格翰跨边界研究全球负责人Henri Doods博士充

富士胶片助力中国首本上消化道早癌 BLI 病理对照图谱正式发布

上海 2019 年 8 月 19 日 / 美通社 / -- 8 月 17 日,正值 2019 中国内镜医师大会期间,由海军军医大学附属长海医院(以下简称 “长海医院”)与富士胶片(中国)投资有限公司(以下简称“富士胶片(中国)”)共同举办的“消化道早癌新技术经验交流会暨《上消化道早癌蓝光成像与病理对照图谱》新书发布会” 在武汉顺利举行。